Featured Research

from universities, journals, and other organizations

Protein switch controls how stem cells turn into new heart tissue

Date:
July 15, 2011
Source:
University of Oxford
Summary:
Researchers have identified a protein that can direct stem cells to become either new heart muscle or blood vessels. The research, which was carried out in zebrafish, offers insight into how it might be possible one day to generate tissues to repair the human heart after damage inflicted by a heart attack.

Oxford University researchers have identified a protein that can direct stem cells to become either new heart muscle or blood vessels. The research, which was carried out in zebrafish, offers insight into how it might be possible one day to generate tissues to repair the human heart after damage inflicted by a heart attack.

The scientists, based at the MRC Molecular Haematology Unit at the University of Oxford, identified a protein called 'fibroblast growth factor' (Fgf) as the controlling factor which determines whether developing heart cells become heart muscle or blood vessels.

They showed that manipulating levels of Fgf in zebrafish embryos could determine how much of each cell type was made.

The research, funded by the Medical Research Council and British Heart Foundation, is published in the journal Development.

Dr Filipa Simoes, one of the first authors of the study, said: 'Our study shows how having the correct concentrations of Fgf in the developing zebrafish heart ensures that the different cell types form properly.

'Crucially, we were able to convert blood and blood vessel cells into heart muscle cells by flipping genetic switches controlled by Fgf. The important next step to this research will be to identify the relevant cells in the human heart and take this finding to the next level.'

Professor Roger Patient, who led the research at the University of Oxford, explained: 'If we can manipulate these heart cells in fish embryos, in the longer term we can look to try and do the same in human hearts -- even adult hearts -- if we can identify the equivalent cells. This could bring significant benefit to heart attack patients or people with heart defects.'

Professor Patient adds that early-stage studies in the lab like this are crucial in turning the potential of stem cells into effective treatments that can help patients recover from heart attacks.

'At the very least, our research will help the production of these cells in the laboratory for use in heart repair. Mending a damaged heart requires new muscle and associated blood vessels. Therefore there is great interest in identifying and manipulating cells that make both.'

The researchers also propose that these cells in the fish, with the potential to make both heart muscle and vessels, may represent cells which played an important role in evolution. Over millions of years they may have been responsible for an increase the amount of cardiac muscle, enabling the heart to grow in size from two chambers in the zebrafish to four chambers in humans.

Professor Jeremy Pearson, associate medical director at the British Heart Foundation, who co-funded the study, said: 'This excellent study throws new light on how our four-chambered hearts evolved from the simpler structures we see in other animals. The results significantly increase our understanding of the origins of stem cells found in the adult heart. This provides important clues to researchers working towards the goal of mending broken hearts after heart attack.'


Story Source:

The above story is based on materials provided by University of Oxford. Note: Materials may be edited for content and length.


Journal Reference:

  1. F. C. Simoes, T. Peterkin, R. Patient. Fgf differentially controls cross-antagonism between cardiac and haemangioblast regulators. Development, 2011; 138 (15): 3235 DOI: 10.1242/dev.059634

Cite This Page:

University of Oxford. "Protein switch controls how stem cells turn into new heart tissue." ScienceDaily. ScienceDaily, 15 July 2011. <www.sciencedaily.com/releases/2011/07/110714100033.htm>.
University of Oxford. (2011, July 15). Protein switch controls how stem cells turn into new heart tissue. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/07/110714100033.htm
University of Oxford. "Protein switch controls how stem cells turn into new heart tissue." ScienceDaily. www.sciencedaily.com/releases/2011/07/110714100033.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins